Bipolar Disorder Trial, Recruiting (NCT06059313)

Bipolar Disorder Trial, Recruiting NCT06059313 Sponsor: Nantes University Hospital Condition: Bipolar Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06059313 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bipolar Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People diagnosed with a specific type of dementia affecting behaviour and personality (called behavioural variant frontotemporal disorder), based on recognised medical diagnostic standards
People who show early or possible signs of frontotemporal dementia but have no abnormalities visible on brain scans
People diagnosed with a frontal variant of Alzheimer's disease, based on recognised medical diagnostic standards
People diagnosed with bipolar disorder, based on recognised medical diagnostic standards
People whose score on a standard memory and thinking test (called the Mini-Mental State Examination) is 18 or above, indicating a certain level of cognitive function
People who have a caregiver (such as a family member or close friend) who knew them well during the 10 years before their illness began
People (and their caregiver) who have given their agreement to take part in the trial

Who may not be able to join:

People who do not have a caregiver available
Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33 2 40 16 54 22

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06059313

Sponsor: Nantes University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Bipolar Disorder

Trial contact: 33 2 40 16 54 22

More information: https://clinicaltrials.gov/study/NCT06059313

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People diagnosed with a specific type of dementia affecting behaviour and personality (called behavioural variant frontotemporal disorder), based on recognised medical diagnostic standards
People who show early or possible signs of frontotemporal dementia but have no abnormalities visible on brain scans
People diagnosed with a frontal variant of Alzheimer's disease, based on recognised medical diagnostic standards
People diagnosed with bipolar disorder, based on recognised medical diagnostic standards
People whose score on a standard memory and thinking test (called the Mini-Mental State Examination) is 18 or above, indicating a certain level of cognitive function
People who have a caregiver (such as a family member or close friend) who knew them well during the 10 years before their illness began
People (and their caregiver) who have given their agreement to take part in the trial

Who may not be able to join:

People who do not have a caregiver available
Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nantes University Hospital

Registry

ClinicalTrials.gov

Start date

14 December 2023

Est. completion

14 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Premorbid personality traits

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov